Entity Common Stock, Shares Outstanding of Alaunos Therapeutics, Inc. from 01 Nov 2010 to 14 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Alaunos Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Nov 2010 to 14 Nov 2025.
  • Alaunos Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 14 Nov 2025 was 2,231,829, a 39% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Alaunos Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,231,829 +630,577 +39% 14 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 2,194,941 +593,689 +37% 14 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,601,252 -14,411,227 -90% 31 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 1,601,252 -239,025,803 -99% 14 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 1,601,252 -239,025,803 -99% 13 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 16,012,479 -224,614,576 -93% 27 Mar 2024 10-K 01 Apr 2024 2023 FY
Q3 2023 240,627,055 +24,445,013 +11% 09 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 240,627,055 +24,452,513 +11% 10 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 240,627,055 +24,499,612 +11% 02 Mar 2023 10-K 07 Mar 2023 2022 FY
Q3 2022 216,182,042 +36,216 +0.02% 09 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 216,174,542 +615,394 +0.28% 10 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 216,127,443 +602,032 +0.28% 21 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 216,145,826 +1,854,769 +0.87% 29 Oct 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 215,559,148 +1,408,208 +0.66% 31 Jul 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 215,525,411 +1,239,074 +0.58% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 214,291,057 +33,261,037 +18% 29 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 214,150,940 +51,597,977 +32% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 214,286,337 +51,891,843 +32% 24 Apr 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 212,999,979 14 Feb 2020 10-K 02 Mar 2020 2019 FY
Q3 2019 181,030,020 +38,650,250 +27% 31 Oct 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 162,552,963 +20,173,193 +14% 24 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 162,394,494 +19,995,558 +14% 30 Apr 2019 10-Q 08 May 2019 2019 Q1
Q3 2018 142,379,770 +416,981 +0.29% 31 Oct 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 142,379,770 +416,981 +0.29% 24 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 142,398,936 +10,017,266 +7.6% 24 Apr 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 141,962,789 +10,230,366 +7.8% 31 Oct 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 141,962,789 +10,230,366 +7.8% 24 Jul 2017 10-Q 31 Jul 2017 2017 Q2
Q1 2017 132,381,670 +541,242 +0.41% 24 Apr 2017 10-Q 01 May 2017 2017 Q1
Q4 2016 132,376,670 +658,091 +0.5% 06 Feb 2017 10-K 16 Feb 2017 2016 FY
Q3 2016 131,732,423 +843,522 +0.64% 03 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 131,732,423 +880,362 +0.67% 09 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 131,840,428 +3,607,891 +2.8% 26 Apr 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 131,718,579 +17,024,255 +15% 10 Feb 2016 10-K 24 Feb 2016 2015 FY
Q3 2015 130,888,901 +28,177,417 +27% 26 Oct 2015 10-Q 02 Nov 2015 2015 Q3
Q2 2015 130,852,061 +30,109,172 +30% 25 Jul 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 128,232,537 +27,506,561 +27% 01 May 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 114,694,324 +14,137,699 +14% 10 Feb 2015 10-K 26 Feb 2015 2014 FY
Q3 2014 102,711,484 +19,015,455 +23% 30 Oct 2014 10-Q 30 Oct 2014 2014 Q3
Q2 2014 100,742,889 +17,220,126 +21% 31 Jul 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 100,725,976 +17,163,197 +21% 30 Apr 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 100,556,625 10 Feb 2014 10-K 03 Mar 2014 2013 FY
Q3 2013 83,696,029 +4,076,432 +5.1% 14 Oct 2013 10-Q 22 Oct 2013 2013 Q3
Q2 2013 83,522,763 +3,954,817 +5% 31 Jul 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 83,562,779 +4,040,277 +5.1% 01 May 2013 10-Q 07 May 2013 2013 Q1
Q3 2012 79,619,597 +11,168,273 +16% 26 Oct 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 79,567,946 +11,165,937 +16% 29 Jul 2012 10-Q/A 28 Aug 2012 2012 Q2
Q1 2012 79,522,502 23 Apr 2012 10-Q 03 May 2012 2012 Q1
Q3 2011 68,451,324 +19,893,646 +41% 28 Oct 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 68,402,009 27 Jul 2011 10-Q/A 09 Aug 2011 2011 Q2
Q3 2010 48,557,678 01 Nov 2010 10-Q 01 Aug 2011 2010 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.